Intravenous antibiotics at home in children with cystic fibrosis
A recent major advance in the management of cystic fibrosis (CF) has been the use of intravenous antibiotic therapy at home. The former reluctance to use intravenous antibiotics at all was partly attributable to the extreme unpleasantness of the regimen. Carbenicillin when infused in high dosage caused considerable pain as a result of venous irritation. The need for estimation of serum levels when aminoglycosides were used never endeared them to the paediatric patient whose life was already dominated by the fear of a painful infusion. Avoidance of intravenous antibiotics was also caused by a pessimistic and defeatist attitude about CF therapy in general, a philosophy still prevalent in some district hospitals, but not be found in any of the larger CF centres in the United Kingdom'. The introduction of non-irritant and non-toxic intravenous anti-pseudomonas antibiotics with a wide safety margin, most notably ceftazidime, has completely altered the approach to therapy. It is now common practice, in some or all patients with CF whose lungs are colonized by Pseudomonas aeruginosa2, to routinely administer intravenously ceftazidime or other anti-pseudomonas antibiotics every three months for approximately 14 days.
Enthusiasm for this more vigorous and aggressive approach, which possibly brings a better hope for survival3, has been dampened by the enormous disruption to schooling, home life and the family brought about by spending 8 out of 52 weeks per year in hospital. Much pressure for the same treatment to be given at home has come from parents, eager to perform the task of drug administration which they perceive to be simple. Other drawbacks to treatment in hospital have been identified2. The shortage of nursing staff approved to administer intravenous drugs and the increasing pressures on the resident medical staff mean that intravenous antibiotics are commonly received many hours late. A shortage ofhospital beds can mean that it may not be possible to accommodate patients for three monthly courses of inpatient treatment, so that important therapy can be delayed for weeks or months. The abysmal system whereby most British hospital physiotherapy departments only perform routine treatment between the hours of 0900 and 1700 h means that twice daily chest physiotherapy, which ought to be given on waking at say 0730 h and on retiring at say 2100 h, is in fact often given at 1100 and 1500 h. In short, many parents quite reasonably feel that treatment could far more effectively be given at home.
Worries about the potential legal problems of giving intravenous antibiotics at home have been dispelled; home treatment poses no special inherent legal difficulties4. There are eight criteria for the selection of patients, all of which must be met before home treatment can be entertained. These are:
(1) Intravenous access should be reliable enough to ensure several days oftreatment without the need to change the cannula. Children with difflcult veins, where the cannula needs to be replaced frequently, are not ideal candidates for home therapy. (2) The patient should be old enough (usually over two years) to cooperate with an intravenous infusion. Parents cannot be expected to safely administer intravenous antibiotics while at the same time trying to restrain a child who is thrashing about.
(3) The patient should have had at least two courses of the same intravenous antibiotics in hospital, to allow sufficient time to train the parents, and to ensure that the patient does not react adversely to the antibiotics in use. Careful teaching of the parents is essential, and it may take several courses of inpatient treatment before the parents and staff are confident that training is complete. (4) The general practitioner must be fully agreeable to home treatment, and in our unit this agreement includes prescribing the antibiotics. (5) The family should have a telephone at home. (6) The child should not be acutely ill. We use home treatment for routine therapy, or for completion of therapy initiated in hospital because of an acute illness. (7) The family should be keen to undertake home therapy. Not all families want to have home treatment, and it would, clearly be unwise to pressurize such families, for example, because of shortage of hospital beds. (8) Certain families are unsuitable for home treatment, because of social problems, poor understanding, or non-compliance. Turning down a request for home treatment on these grounds is not easy and demands great diplomacy. Intravenous access is usually by cannula, kept patent between doses of antibiotics with heparinized saline. Intermittent injection is favoured by some older patients with prominent veins. Some centres favour the use of implantable intravenous access devices or silastic catheter 'long lines', although both devices suffer from the potential for alarming and insufficiently appreciated serious risks such as catheter fracture, displacement, embolism, vascular perforation, thrombosis or endocarditis5-11. The cannula is inserted in hospital, and the patient kept in hospital for observation for an arbitrary period (for example an hour) in case of an adverse reaction after the first dose ofantibiotic has been given. If a cannula becomes blocked or dislodged, then the patient is returned to the ward and the cannula replaced.
Home treatment with intravenous antibiotics is now well established12-'5. A real worry is that parents undertaking a potentially dangerous procedure have to make a sudden leap from performing the task under close supervision in hospital to doing so at home with no help or support at all. In our hands' this has not led to any problems of which we are aware. However, it is in this situation that a liaison CF nurse, if one is available, comes into her own, for she can monitor progress and compliance in the home and provide important support to the parents and feedback to the hospital'4"5.
Other advances in the management of cystic fibrosis include improved nutritional support, the early detection of lung function abnormalities, the management of cor pulmonale, the use of autogenic drainage during physiotherapy, the recognition and management of pseudo-Bartter's syndrome, and
